The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40
Abstract
Molecular studies suggest that the simian polyomavirus SV40 is present in the human population, possibly introduced in contaminated polio vaccine. However, no recent seroepidemiological data exist in England on SV40 or on the two human polyomaviruses, BKV and JCV. A comparative age seroprevalence study was undertaken on 2,435 residual sera from 1991 by haemagglutination inhibition (HI) for BKV and JCV, and virus neutralisation for SV40. The overall rates of seropositivity for BKV and JCV were 81% and 35%, respectively, and each was significantly related to age (P < 0.001). BKV seroprevalence reached 91% at 5–9 years of age, but JCV seroprevalence reached only 50% by age 60–69 years. There was a highly significant association between BKV antibody titre and age (P < 0.001), titres decreasing linearly at a rate of 8.7% per 10 years (95% CI = 7.4–10% drop). Significantly more males than females had antibody to JCV (P = 0.013). In individuals under 40 years of age there was a significant negative association between the presence of antibody to BKV and JCV (P < 0.001). By contrast, the antibody prevalence to SV40 remained at 1.3–5% throughout all age groups and titres were low. There was a significant positive association between the presence of antibody to SV40 and antibody to both BKV (P < 0.001) and JCV (P = 0.009), and also to the geometric mean titre (GMT) of BKV antibody (P = 0.011). The results indicate that BKV and JCV are transmitted by different routes. There is no serological evidence that SV40 entered the human population during the past 80 years, and the possibility of cross‐reaction with BKV or JCV antibody must be considered. J. Med. Virol. 71:115–123, 2003. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NEW HUMAN PAPOVAVIRUS (B.K.) ISOLATED FROM URINE AFTER RENAL TRANSPLANTATION
Gardner, S., Field, A., Coleman, D., & Hulme, B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91776-4 · Cited by 1,497
Sweet, B. H., & Hilleman, M. R. (1960) · Experimental Biology and Medicine · doi:10.3181/00379727-105-26128 · Cited by 515
Padgett, B. L., & Walker, D. L. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/127.4.467 · Cited by 479
Bergsagel, D. J., Finegold, M. J., Butel, J. S., Kupsky, W. J., & Garcea, R. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261504 · Cited by 415
Simian virus 40-like DNA sequences in human pleural mesothelioma.
Carbone, M., Pass, H. I., Rizzo, P., Marinetti, M. R., Muzio, M. D., Mew, D., Levine, A. S., & Procopio, A. D. (1994) · PubMed · Cited by 397
HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12
SHAH, K., & NATHANSON, N. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112197 · Cited by 339
Isolation of Virus Related to SV40 from Patients with Progressive Multifocal Leukoencephalopathy
Weiner, L. P., Herndon, R. M., Narayan, O., Johnson, R. T., Shah, K. V., Rubinstein, L. J., Preziosi, T. J., & Conley, F. K. (1972) · New England Journal of Medicine · doi:10.1056/nejm197202242860801 · Cited by 287
Prevalence in England of Antibody to Human Polyomavirus (B.K.)
Gardner, S. D. (1973) · BMJ · doi:10.1136/bmj.1.5845.77 · Cited by 256
De Luca, A., Baldi, A., Esposito, V., Howard, C. M., Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-913 · Cited by 211
Martini, F., Iaccheri, L., Lazzarin, L., Carinci, P., Corallini, A., Gerosa, M. A., Iuzzolino, P., Barbanti-Brodano, G., & Tognon, M. G. (1996) · PubMed · Cited by 205
Association between simian virus 40 and non-Hodgkin lymphoma
Vilchez, R. A., Madden, C. R., Kozinetz, C. A., Halvorson, S. J., White, Z. S., Jorgensen, J. L., Finch, C. J., & Butel, J. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07950-3 · Cited by 200
Jin, L., Gibson, P. E., Booth, J. C., & Clewley, J. P. (1993) · Journal of Medical Virology · doi:10.1002/jmv.1890410104 · Cited by 154
Presence of simian virus 40 DNA sequences in human lymphomas
Shivapurkar, N., Harada, K., Reddy, J., Scheuermann, R. H., Xu, Y., McKenna, R. W., Milchgrub, S., Kroft, S. H., Feng, Z., & Gazdar, A. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07921-7 · Cited by 150
Padgett, B. L., Rogers, C. M., & Walker, D. L. (1977) · Infection and Immunity · doi:10.1128/iai.15.2.656-662.1977 · Cited by 149
Parent-to-child transmission is relatively common in the spread of the human polyomavirus JC virus
Kunitake, T., Kitamura, T., Guo, J., TAGUCHI, F., Kawabe, K., & Yogo, Y. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.6.1448-1451.1995 · Cited by 140
JC Papovavirus in Progressive Multifocal Leukoencephalopathy
Padgett, B. L., Walker, D. L., ZuRhein, G. M., Hodach, A. E., & Chou, S. M. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.6.686 · Cited by 137
Human Papovavirus, BK Strain: Biological Studies Including Antigenic Relationship to Simian Virus 40
Takemoto, K. K., & Mullarkey, M. F. (1973) · Journal of Virology · doi:10.1128/jvi.12.3.625-631.1973 · Cited by 135
Transmission of the human polyomavirus JC virus occurs both within the family and outside the family
Kitamura, T., Kunitake, T., Guo, J., Tominaga, T., Kawabe, K., & Yogo, Y. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.10.2359-2363.1994 · Cited by 109
Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations
Shivapurkar, N., Wiethege, T., Wistuba, I. I., Salomon, E., Milchgrub, S., Müller, K.-M., Churg, A., Pass, H. I., & Gazdar, A. F. (2000) · Journal of Cellular Biochemistry · Cited by 108
Sundsfjord, A., Spein, A. R., Lucht, E., Flægstad, T., Seternes, O. M., & Traavik, T. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1390-1394.1994 · Cited by 104
Shah, K. V., Daniel, R. W., Strickler, H. D., & Goedert, J. J. (1997) · The Journal of Infectious Diseases · doi:10.1086/517340 · Cited by 83
Fedele, C. G., Ciardi, M. R., Delia, S., Echevarría, J. M., & Tenório, A. (1999) · Journal of Virological Methods · doi:10.1016/s0166-0934(99)00095-6 · Cited by 81
Examination of Poliovirus Vaccine Preparations for SV40 Sequences
Sangar, D. V., Pipkin, P. A., Wood, D. J., & Minor, P. D. (1999) · Biologicals · doi:10.1006/biol.1998.0170 · Cited by 34
Self-citationStrickler, H. D., & Goedert, J. J. (1998) · PubMed · Cited by 29
Cited by
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Kleinschmidt-DeMasters, B. K., & Tyler, K. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051782 · Cited by 1,072
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
Egli, A., Infanti, L., Dumoulin, A., Buser, A., Samaridis, J., Stebler, C., Gosert, R., & Hirsch, H. H. (2009) · The Journal of Infectious Diseases · doi:10.1086/597126 · Cited by 781
Tan, C. S., & Koralnik, I. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70040-5 · Cited by 776
Metadata
- Authors
- Knowles, W. A., Pipkin, P., Andrews, N., Vyse, A., Minor, P., Brown, D. W. G., & Miller, E.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2003-07-08
- Volume
- 71
- Issue
- 1
- Pages
- 115-123
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W2067486972
- Cited by
- 586
- References
- 24
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.